- Home
- GERN vs EFSC Comparison
GERN vs EFSC Comparison
Compare GERN & EFSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- EFSC
- Stock Information
- Founded
- GERN 1990
- EFSC 1988
- Country
- GERN United States
- EFSC United States
- Employees
- GERN N/A
- EFSC N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- EFSC Major Banks
- Sector
- GERN Health Care
- EFSC Finance
- Exchange
- GERN Nasdaq
- EFSC Nasdaq
- Market Cap
- GERN 2.5B
- EFSC 2.2B
- IPO Year
- GERN 1996
- EFSC 1999
- Fundamental
- Price
- GERN $3.93
- EFSC $58.37
- Analyst Decision
- GERN Strong Buy
- EFSC Strong Buy
- Analyst Count
- GERN 10
- EFSC 4
- Target Price
- GERN $7.05
- EFSC $56.50
- AVG Volume (30 Days)
- GERN 6.7M
- EFSC 152.9K
- Earning Date
- GERN 11-07-2024
- EFSC 01-21-2025
- Dividend Yield
- GERN N/A
- EFSC 1.88%
- EPS Growth
- GERN N/A
- EFSC N/A
- EPS
- GERN N/A
- EFSC 4.72
- Revenue
- GERN $29,480,000.00
- EFSC $591,631,000.00
- Revenue This Year
- GERN $32,021.10
- EFSC N/A
- Revenue Next Year
- GERN $298.14
- EFSC $0.15
- P/E Ratio
- GERN N/A
- EFSC $12.65
- Revenue Growth
- GERN 9199.68
- EFSC N/A
- 52 Week Low
- GERN $1.64
- EFSC $37.28
- 52 Week High
- GERN $5.34
- EFSC $63.13
- Technical
- Relative Strength Index (RSI)
- GERN 46.32
- EFSC 47.67
- Support Level
- GERN $3.75
- EFSC $58.75
- Resistance Level
- GERN $4.05
- EFSC $60.99
- Average True Range (ATR)
- GERN 0.16
- EFSC 1.30
- MACD
- GERN -0.01
- EFSC -0.40
- Stochastic Oscillator
- GERN 39.13
- EFSC 6.22
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate, and consumer loans.